ALDX News

ALDX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Aldeyra Therapeutics, Inc. to Contact the Firm Today!

Pomerantz LLP Updates Investors on Legal Action Brought Against Aldeyra Therapeutics, Inc. – ALDX

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Firm - ALDX

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

ALDX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 Ready to Announce with Confidence?

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executive Allegedly Approved Misleading Disclosures: Levi & Korsinsky

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Aldeyra Therapeutics, Inc. to Contact the Firm Today!

Pomerantz LLP Reminds Shareholders with Losses on their Investment in Aldeyra Therapeutics, Inc. of Class Action Lawsuit – ALDX

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX